Concepedia
Author
Benjamin Pariente
Also Known As
B Parent, B Pariente, B. Pariente, Beatriz Pariente, Benjamin Pariente, For the FOCUS Study Group, Maria Nachury, Pariente, B, Pariente, B., Pariente, Benjamin
245
Publications
8K
Citations
39
H-Index
69
Concepts
All Affiliations
1
21
34
2.4K
2
3
83
103
4
12
5
101
×
All Concepts
71
5.1K
35
Development of the Crohnʼs disease digestive damage score, the Lémann score
Benjamin Pariente, Jacques Cosnes, Silvio Danese, +28
Inflammatory Bowel Diseases
2010
576
Development of the Lémann Index to Assess Digestive Tract Damage in Patients With Crohn's Disease
Benjamin Pariente, Jean-Yves Mary, Silvio Danese, +28
Gastroenterology
Functional Gastrointestinal DisorderLémann IndexDiagnosisGastroenterologyPathology +4
2014
304
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease
Geert D’Haens, Séverine Vermeire, Guy Lambrecht, +26
InflammationChronic Inflammatory DiseasesInfliximab DoseImmunologyGastroenterology +6
2018
295
Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease
Ryan C. Ungaro, Clara Yzet, Peter Bossuyt, +35
InflammationChronic Inflammatory DiseasesDeep RemissionAutoimmune DiseaseMucosal Immunology +6
2020
227
Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools
Anthony Buisson, Florent Gonzalez, Florian Poullenot, +23
2017
223
Cephalic Duodenopancreatectomy for Hyperalgic Duodenal Crohn's Disease Fistulized in the Pancreatic Gland
S. Guellouz, Benjamin Pariente, Claire Bénet, +5
Case Reports in Gastroenterology
216
Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
Aurélien Amiot, Jean–Charles Grimaud, Laurent Peyrin‐Biroulet, +86
Clinical Gastroenterology and Hepatology
InflammationAnti-inflammatoryImmunologyGastroenterologyPharmacotherapy +4
2016
189
One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study
Aurélien Amiot, Mélanie Serrero, Laurent Peyrin‐Biroulet, +23
Alimentary Pharmacology & Therapeutics
175
Postoperative Complications after Ileocecal Resection in Crohn’s Disease: A Prospective Study From the REMIND Group
Mathurin Fuméry, Philippe Seksik, Claire Auzolle, +20
The American Journal of Gastroenterology
174
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti–Tumor Necrosis Factor Agents
Pauline Wils, Yoram Bouhnik, Pierre Michetti, +18
InflammationChronic Inflammatory DiseasesAnti-inflammatoryAutoimmune DiseaseCrohn ’ +6
2015
169
Page 1